Medication info
Telmisartan Plus Tablet 40/12.5 mg

Telmisartan Plus Tablet 40/12.5 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Daehwa Pharmaceutical Co., Ltd.
Appearance
White or whitish convex round tablet
Packaging
30 tablets/box [10 tablets/blister X 3]
Approval status
Active

MFDS item code 201902560 · Approved 2019.04.24 · Insurance code 645605020

Summary

Main use
Treatment of essential hypertension not controlled with telmisartan alone
Who takes it
Adults · Children
Adult dose
Adults Take once daily with a drink, with or without food, in patients whose blood pressure is not adequately controlled with telmisartan alone. Before switching to this fixed-dose combination, it is recommended that the doses of the individual components be adjusted separately for each patient. When clinically appropriate, switching directly from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide 40/12.5mg combination may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide 80/12.5mg combination may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide 80/25mg combination may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg taken separately or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dosage adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution to patients with mild to moderate hepatic impairment. The daily dose of this medicine should not exceed 40/12.5mg. This medicine should not be administered to patients with severe hepatic impairment (see Precautions for Use 2.). Thiazide diuretics should be administered with caution to patients with impaired liver function. Elderly patients No dosage adjustment is necessary.
Child dose
The safety and efficacy of this medicine have not been established in children under 18 years of age.

Ingredients

Manufacturer
Daehwa Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with telmisartan alone

  • Essential hypertension
View approved original text

This medication is used to treat essential hypertension. It is particularly helpful for patients whose blood pressure is not adequately controlled with telmisartan alone, allowing for effective reduction in blood pressure when administered additionally. This contributes to reducing the risk of cardiovascular diseases and improving health.

How to take

Adult dose

Adults Take once daily with a drink, with or without food, in patients whose blood pressure is not adequately controlled with telmisartan alone. Before switching to this fixed-dose combination, it is recommended that the doses of the individual components be adjusted separately for each patient. When clinically appropriate, switching directly from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide 40/12.5mg combination may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide 80/12.5mg combination may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide 80/25mg combination may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg taken separately or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dosage adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution to patients with mild to moderate hepatic impairment. The daily dose of this medicine should not exceed 40/12.5mg. This medicine should not be administered to patients with severe hepatic impairment (see Precautions for Use 2.). Thiazide diuretics should be administered with caution to patients with impaired liver function. Elderly patients No dosage adjustment is necessary.

Child dose

The safety and efficacy of this medicine have not been established in children under 18 years of age.

Precautions

This medication should not be used during pregnancy, especially in the second and third trimesters, as it can cause serious harm to the fetus. Patients with allergies to any of the ingredients in this medication or with certain liver or kidney diseases should not take this medication. Elderly patients or those with high potassium levels, liver impairment, etc., should take this medication cautiously, and their condition should be monitored regularly. As this medication lowers blood pressure, symptoms such as hypotension, dizziness, and fainting may occur, requiring careful attention. Due to the hydrochlorothiazide component, the skin may become sensitive to sunlight; hence, exposure to sunlight should be avoided, and if any abnormal symptoms occur, consultation with a doctor should be sought immediately. This medication may affect kidney function, so patients with kidney disease should undergo regular blood tests and electrolyte tests. There are many interactions with other medications, so if you are taking any other medications, you must inform your doctor or pharmacist, especially when combined with lithium, potassium-sparing agents, diuretics, and antihypertensives. Caution is required when driving or operating machinery as dizziness or drowsiness may occur. In case of overdose, symptoms such as hypotension, electrolyte imbalance, and dehydration may occur, requiring immediate medical attention. Safety and efficacy have not been established for children or adolescents under 18 years of age.

Side effects

  • Bronchitis
  • pharyngitis
  • sinusitis
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
  • insomnia
  • sleep disorders
Show 121 more
  • dizziness
  • fainting
  • paresthesia
  • visual impairment
  • blurred vision
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • respiratory distress
  • pneumonia
  • pulmonary edema
  • diarrhea
  • dry mouth
  • bloating
  • abdominal pain
  • constipation
  • dyspepsia
  • vomiting
  • gastritis
  • liver function abnormalities
  • liver disorders
  • angioedema
  • erythema
  • pruritus
  • rash
  • hyperhidrosis
  • urticaria
  • back pain
  • muscle spasms
  • myalgia
  • arthralgia
  • limb pain
  • systemic lupus erythematosus
  • erectile dysfunction
  • chest pain
  • influenza-like illness
  • pain
  • increased blood uric acid
  • increased blood creatinine
  • increased blood creatine phosphokinase
  • elevated liver enzymes
  • upper respiratory tract infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • eosinophilia
  • thrombocytopenia
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • drowsiness
  • bradycardia
  • cough
  • interstitial lung disease
  • dry mouth
  • abdominal discomfort
  • dysgeusia
  • eczema
  • drug rash
  • toxic epidermal necrolysis
  • bone pain
  • kidney dysfunction
  • myasthenia
  • influenza-like illness
  • increased blood creatinine
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • sialadenitis
  • non-melanoma skin cancer
  • thrombocytopenic purpura
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • hypersensitivity
  • jaundice
  • cholestasis
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • lupus-like syndrome
  • acute renal failure
  • diabetes
  • kidney dysfunction
  • myasthenia
  • fever
  • nausea
  • abdominal pain
  • gastrointestinal bleeding
  • esophagitis
  • headache
  • tremors
  • facial flushing
  • malaise
  • fatigue
  • weight loss
  • proteinuria
  • itchiness
  • myalgia
  • sense of floating
  • lip and hand tremors
  • hypersensitivity
  • vision impairment
  • hypotension
  • tachycardia
  • bradycardia
  • drowsiness
  • nausea
  • somnolence
  • muscle cramps
  • pulmonary edema
  • acute respiratory distress syndrome
  • acute myopia
  • angle-closure glaucoma
  • choroidal effusion
  • acute respiratory distress syndrome
  • intestinal vascular edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication can be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is best to store the medication at room temperature between 1 and 30 degrees Celsius. Avoid storing it in excessively hot or cold places to maintain its efficacy.

Appearance and packaging

Appearance

White or whitish convex round tablet

Package unit

30 tablets/box [10 tablets/blister X 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.